{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:55:25Z","timestamp":1794027325351,"version":"4.8.0"},"reference-count":230,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1038\/s41584-020-0503-4","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T08:03:07Z","timestamp":1601625787000},"page":"628-644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":156,"title":["Sex steroids and autoimmune rheumatic diseases: state of the art"],"prefix":"10.1038","volume":"16","author":[{"given":"Maurizio","family":"Cutolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer H.","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,2]]},"reference":[{"key":"503_CR1","first-page":"161","volume":"13","author":"PS Hench","year":"1938","unstructured":"Hench, P. S. The ameliorating effect of pregnancy on chronic atrophic (infectious, rheumatoid) arthritis, fibrositis, and intermittent hydrarthrosis. Proc. Staff. Meet. Mayo Clin. 13, 161\u2013167 (1938).","journal-title":"Proc. Staff. Meet. Mayo Clin."},{"key":"503_CR2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni0901-777","volume":"2","author":"CC Whitacre","year":"2001","unstructured":"Whitacre, C. C. Sex differences in autoimmune disease. Nat. Immunol. 2, 777\u2013780 (2001).","journal-title":"Nat. Immunol."},{"key":"503_CR3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bpobgyn.2019.03.001","volume":"60","author":"M Benagiano","year":"2019","unstructured":"Benagiano, M., Bianchi, P., D\u2019Elios, M. M., Brosens, I. & Benagiano, G. Autoimmune diseases: role of steroid hormones. Best Pract. Res. Clin. Obstet. Gynaecol. 60, 24\u201334 (2019).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"503_CR4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.2009.05293.x","volume":"1193","author":"MD Lockshin","year":"2010","unstructured":"Lockshin, M. D. Nonhormonal explanations for sex discrepancy in human illness. Ann. N. Y. Acad. Sci. 1193, 22\u201324 (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"503_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0961203318815768","volume":"28","author":"EAA Christou","year":"2019","unstructured":"Christou, E. A. A., Banos, A., Kosmara, D., Bertsias, G. K. & Boumpas, D. T. Sexual dimorphism in SLE: above and beyond sex hormones. Lupus 28, 3\u201310 (2019).","journal-title":"Lupus"},{"key":"503_CR6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41584-019-0307-6","volume":"15","author":"NC Lambert","year":"2019","unstructured":"Lambert, N. C. Nonendocrine mechanisms of sex bias in rheumatic diseases. Nat. Rev. Rheumatol. 15, 673\u2013686 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"503_CR7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0889-857X(05)70171-X","volume":"26","author":"M Cutolo","year":"2000","unstructured":"Cutolo, M. & Wilder, R. L. Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases. Rheum. Dis. Clin. North Am. 26, 825\u2013839 (2000).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"503_CR8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","volume":"28","author":"RH Straub","year":"2007","unstructured":"Straub, R. H. The complex role of estrogens in inflammation. Endocr. Rev. 28, 521\u2013574 (2007).","journal-title":"Endocr. Rev."},{"key":"503_CR9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/0961203308089402","volume":"17","author":"JF Cohen-Solal","year":"2008","unstructured":"Cohen-Solal, J. F. et al. Hormonal regulation of B-cell function and systemic lupus erythematosus. Lupus 17, 528\u2013532 (2008).","journal-title":"Lupus"},{"key":"503_CR10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/ar2804","volume":"11","author":"M Cutolo","year":"2009","unstructured":"Cutolo, M. Androgens in rheumatoid arthritis: when are they effectors? Arthritis Res. Ther. 11, 126 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"503_CR11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mce.2010.05.018","volume":"335","author":"U Islander","year":"2011","unstructured":"Islander, U., Jochems, C., Lagerquist, M. K., Forsblad-d\u2019Elia, H. & Carlsten, H. Estrogens in rheumatoid arthritis; the immune system and bone. Mol. Cell. Endocrinol. 335, 14\u201329 (2011).","journal-title":"Mol. Cell. Endocrinol."},{"key":"503_CR12","doi-asserted-by":"crossref","first-page":"A460","DOI":"10.1016\/j.autrev.2011.11.014","volume":"11","author":"M Cutolo","year":"2012","unstructured":"Cutolo, M., Sulli, A. & Straub, R. H. Estrogen metabolism and autoimmunity. Autoimmun. Rev. 11, A460\u2013A464 (2012).","journal-title":"Autoimmun. Rev."},{"key":"503_CR13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2012.01.004","volume":"39","author":"YT Konttinen","year":"2012","unstructured":"Konttinen, Y. T. et al. Sex steroids in Sj\u00f6gren\u2019s syndrome. J. Autoimmun. 39, 49\u201356 (2012).","journal-title":"J. Autoimmun."},{"key":"503_CR14","doi-asserted-by":"crossref","first-page":"A502","DOI":"10.1016\/j.autrev.2011.12.003","volume":"11","author":"GC Hughes","year":"2012","unstructured":"Hughes, G. C. Progesterone and autoimmune disease. Autoimmun. Rev. 11, A502\u2013A514 (2012).","journal-title":"Autoimmun. Rev."},{"key":"503_CR15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrrheum.2014.144","volume":"10","author":"GC Hughes","year":"2014","unstructured":"Hughes, G. C. & Choubey, D. Modulation of autoimmune rheumatic diseases by oestrogen and progesterone. Nat. Rev. Rheumatol. 10, 740\u2013751 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"503_CR16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cellimm.2015.02.004","volume":"294","author":"A Trigunaite","year":"2015","unstructured":"Trigunaite, A., Dimo, J. & Jorgensen, T. N. Suppressive effects of androgens on the immune system. Cell Immunol. 294, 87\u201394 (2015).","journal-title":"Cell Immunol."},{"key":"503_CR17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cellimm.2015.02.002","volume":"294","author":"MR Gubbels Bupp","year":"2015","unstructured":"Gubbels Bupp, M. R. Sex, the aging immune system, and chronic disease. Cell. Immunol. 294, 102\u2013110 (2015).","journal-title":"Cell. Immunol."},{"key":"503_CR18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.clim.2016.08.014","volume":"172","author":"RG Lahita","year":"2016","unstructured":"Lahita, R. G. The immunoendocrinology of systemic lupus erythematosus. Clin. Immunol. 172, 98\u2013100 (2016).","journal-title":"Clin. Immunol."},{"key":"503_CR19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/jcm7120549","volume":"7","author":"A Traish","year":"2018","unstructured":"Traish, A., Bolanos, J., Nair, S., Saad, F. & Morgentaler, A. Do androgens modulate the pathophysiological pathways of inflammation? Appraising the contemporary evidence. J. Clin. Med. 7, 549 (2018).","journal-title":"J. Clin. Med."},{"key":"503_CR20","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3389\/fimmu.2018.00794","volume":"9","author":"MR Gubbels Bupp","year":"2018","unstructured":"Gubbels Bupp, M. R. & Jorgensen, T. N. Androgen-induced immunosuppression. Front. Immunol. 9, 794 (2018).","journal-title":"Front. Immunol."},{"key":"503_CR21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bpobgyn.2019.07.001","volume":"60","author":"J Szekeres-Bartho","year":"2019","unstructured":"Szekeres-Bartho, J. & Schindler, A. E. Progestogens and immunology. Best Pract. Res. Clin. Obstet. Gynaecol. 60, 17\u201323 (2019).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"503_CR22","first-page":"2597","volume":"30","author":"LA Castagnetta","year":"2003","unstructured":"Castagnetta, L. A. et al. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J. Rheumatol. 30, 2597\u20132605 (2003).","journal-title":"J. Rheumatol."},{"key":"503_CR23","first-page":"369","volume":"17","author":"NJ Olsen","year":"1996","unstructured":"Olsen, N. J. & Kovacs, W. J. Gonadal steroids and immunity. Endocr. Rev. 17, 369\u2013384 (1996).","journal-title":"Endocr. Rev."},{"key":"503_CR24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51255-0","volume":"9","author":"JM Sanchez-Maldonado","year":"2019","unstructured":"Sanchez-Maldonado, J. M. et al. Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: results from the REPAIR consortium. Sci. Rep. 9, 14812 (2019).","journal-title":"Sci. Rep."},{"key":"503_CR25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.micpath.2018.12.029","volume":"127","author":"QM Xie","year":"2019","unstructured":"Xie, Q. M. et al. Association of oestrogen receptor alpha gene polymorphisms with systemic lupus erythematosus risk: an updated meta-analysis. Microb. Pathog. 127, 352\u2013358 (2019).","journal-title":"Microb. Pathog."},{"key":"503_CR26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajhg.2014.12.024","volume":"96","author":"MJ Lewis","year":"2015","unstructured":"Lewis, M. J. et al. UBE2L3 polymorphism amplifies NF-\u03baB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am. J. Hum. Genet. 96, 221\u2013234 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"503_CR27","doi-asserted-by":"crossref","first-page":"8716","DOI":"10.1128\/MCB.24.19.8716-8726.2004","volume":"24","author":"S Verma","year":"2004","unstructured":"Verma, S. et al. The ubiquitin-conjugating enzyme UBCH7 acts as a coactivator for steroid hormone receptors. Mol. Cell Biol. 24, 8716\u20138726 (2004).","journal-title":"Mol. Cell Biol."},{"key":"503_CR28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41397-018-0057-x","volume":"19","author":"LM Canet","year":"2019","unstructured":"Canet, L. M. et al. Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients. Pharmacogenomics J. 19, 83\u201396 (2019).","journal-title":"Pharmacogenomics J."},{"key":"503_CR29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13075-015-0574-9","volume":"17","author":"K Stark","year":"2015","unstructured":"Stark, K. et al. CYB5A polymorphism increases androgens and reduces risk of rheumatoid arthritis in women. Arthritis Res. Ther. 17, 56 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"503_CR30","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa073491","volume":"357","author":"RM Plenge","year":"2007","unstructured":"Plenge, R. M. et al. TRAF1-C5 as a risk locus for rheumatoid arthritis \u2014 a genomewide study. N. Engl. J. Med. 357, 1199\u20131209 (2007).","journal-title":"N. Engl. J. Med."},{"key":"503_CR31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","volume":"447","author":"Wellcome Trust Case Control Consortium","year":"2007","unstructured":"Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661\u2013678 (2007).","journal-title":"Nature"},{"key":"503_CR32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2011.08.006","volume":"352","author":"J Jaaskelainen","year":"2012","unstructured":"Jaaskelainen, J. Molecular biology of androgen insensitivity. Mol. Cell. Endocrinol. 352, 4\u201312 (2012).","journal-title":"Mol. Cell. Endocrinol."},{"key":"503_CR33","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s10067-007-0616-z","volume":"26","author":"SF Yu","year":"2007","unstructured":"Yu, S. F. et al. Association of tri-nucleotide (CAG and GGC) repeat polymorphism of androgen receptor gene in Taiwanese women with refractory or remission rheumatoid arthritis. Clin. Rheumatol. 26, 2051 (2007).","journal-title":"Clin. Rheumatol."},{"key":"503_CR34","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar2742","volume":"11","author":"EW Karlson","year":"2009","unstructured":"Karlson, E. W. et al. A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis. Arthritis Res. Ther. 11, R97 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"503_CR35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3899\/jrheum.110894","volume":"39","author":"V Dziedziejko","year":"2012","unstructured":"Dziedziejko, V. et al. CAG repeat polymorphism in the androgen receptor gene in women with rheumatoid arthritis. J. Rheumatol. 39, 10\u201317 (2012).","journal-title":"J. Rheumatol."},{"key":"503_CR36","first-page":"209","volume":"24","author":"SF Lo","year":"2006","unstructured":"Lo, S. F. et al. Androgen receptor gene polymorphism and rheumatoid arthritis in Taiwan. Clin. Exp. Rheumatol. 24, 209\u2013210 (2006).","journal-title":"Clin. Exp. Rheumatol."},{"key":"503_CR37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/ard.58.8.500","volume":"58","author":"T Kawasaki","year":"1999","unstructured":"Kawasaki, T. et al. Polymorphic CAG repeats of the androgen receptor gene and rheumatoid arthritis. Ann. Rheum. Dis. 58, 500\u2013502 (1999).","journal-title":"Ann. Rheum. Dis."},{"key":"503_CR38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10875-011-9519-5","volume":"31","author":"AH Tessnow","year":"2011","unstructured":"Tessnow, A. H., Olsen, N. J. & Kovacs, W. J. Expression of humoral autoimmunity is related to androgen receptor CAG repeat length in men with systemic lupus erythematosus. J. Clin. Immunol. 31, 567\u2013573 (2011).","journal-title":"J. Clin. Immunol."},{"key":"503_CR39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/EC-14-0039","volume":"3","author":"NJ Olsen","year":"2014","unstructured":"Olsen, N. J., Benko, A. L. & Kovacs, W. J. Variation in the androgen receptor gene exon 1 CAG repeat correlates with manifestations of autoimmunity in women with lupus. Endocr. Connect. 3, 99\u2013109 (2014).","journal-title":"Endocr. Connect."},{"key":"503_CR40","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00296-013-2687-2","volume":"33","author":"R Robeva","year":"2013","unstructured":"Robeva, R. et al. Androgen receptor (CAG)n polymorphism and androgen levels in women with systemic lupus erythematosus and healthy controls. Rheumatol. Int. 33, 2031\u20132038 (2013).","journal-title":"Rheumatol. Int."},{"key":"503_CR41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/1756-185X.12011","volume":"16","author":"SF Yu","year":"2013","unstructured":"Yu, S. F. et al. Androgen receptor genetic variants in male patients with ankylosing spondylitis in Taiwan. Int. J. Rheum. Dis. 16, 81\u201387 (2013).","journal-title":"Int. J. Rheum. Dis."},{"key":"503_CR42","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/rheumatology\/39.5.530","volume":"39","author":"K Mori","year":"2000","unstructured":"Mori, K., Ushiyama, T., Inoue, K. & Hukuda, S. Polymorphic CAG repeats of the androgen receptor gene in Japanese male patients with ankylosing spondylitis. Rheumatology 39, 530\u2013532 (2000).","journal-title":"Rheumatology"},{"key":"503_CR43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev-genet-110410-132459","volume":"45","author":"DP Barlow","year":"2011","unstructured":"Barlow, D. P. Genomic imprinting: a mammalian epigenetic discovery model. Annu. Rev. Genet. 45, 379\u2013403 (2011).","journal-title":"Annu. Rev. Genet."},{"key":"503_CR44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molimm.2014.05.002","volume":"61","author":"HW Liu","year":"2014","unstructured":"Liu, H. W. et al. Demethylation within the proximal promoter region of human estrogen receptor alpha gene correlates with its enhanced expression: implications for female bias in lupus. Mol. Immunol. 61, 28\u201337 (2014).","journal-title":"Mol. Immunol."},{"key":"503_CR45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/ced.12346","volume":"39","author":"Z Wu","year":"2014","unstructured":"Wu, Z. et al. 17\u03b2-oestradiol enhances global DNA hypomethylation in CD4-positive T cells from female patients with lupus, through overexpression of oestrogen receptor-\u03b1-mediated downregulation of DNMT1. Clin. Exp. Dermatol. 39, 525\u2013532 (2014).","journal-title":"Clin. Exp. Dermatol."},{"key":"503_CR46","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3389\/fimmu.2017.01932","volume":"8","author":"S Alivernini","year":"2017","unstructured":"Alivernini, S. et al. MicroRNA-155-at the critical interface of innate and adaptive immunity in arthritis. Front. Immunol. 8, 1932 (2017).","journal-title":"Front. Immunol."},{"key":"503_CR47","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1182\/blood-2008-04-152488","volume":"112","author":"R Dai","year":"2008","unstructured":"Dai, R. et al. Suppression of LPS-induced Interferon-\u03b3 and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 112, 4591\u20134597 (2008).","journal-title":"Blood"},{"key":"503_CR48","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3389\/fimmu.2018.01903","volume":"9","author":"ML Dupuis","year":"2018","unstructured":"Dupuis, M. L. et al. The natural agonist of estrogen receptor \u03b2 silibinin plays an immunosuppressive role representing a potential therapeutic tool in rheumatoid arthritis. Front. Immunol. 9, 1903 (2018).","journal-title":"Front. Immunol."},{"key":"503_CR49","volume":"8","author":"WW Tong","year":"2018","unstructured":"Tong, W. W. et al. Silibinin alleviates inflammation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes and has a therapeutic effect on arthritis in rats. Sci. Rep. 8, 3241 (2018).","journal-title":"Sci. Rep."},{"key":"503_CR50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cellimm.2015.01.004","volume":"294","author":"D Khan","year":"2015","unstructured":"Khan, D., Dai, R. & Ansar Ahmed, S. Sex differences and estrogen regulation of miRNAs in lupus, a prototypical autoimmune disease. Cell Immunol. 294, 70\u201379 (2015).","journal-title":"Cell Immunol."},{"key":"503_CR51","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/08916934.2014.915955","volume":"47","author":"H Zan","year":"2014","unstructured":"Zan, H., Tat, C. & Casali, P. MicroRNAs in lupus. Autoimmunity 47, 272\u2013285 (2014).","journal-title":"Autoimmunity"},{"key":"503_CR52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fimmu.2018.00098","volume":"9","author":"R Perniola","year":"2018","unstructured":"Perniola, R. Twenty years of AIRE. Front. Immunol. 9, 98 (2018).","journal-title":"Front. Immunol."},{"key":"503_CR53","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1172\/JCI81894","volume":"126","author":"N Dragin","year":"2016","unstructured":"Dragin, N. et al. Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases. J. Clin. Invest. 126, 1525\u20131537 (2016).","journal-title":"J. Clin. Invest."},{"key":"503_CR54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20080521","volume":"206","author":"S Pauklin","year":"2009","unstructured":"Pauklin, S., Sernandez, I. V., Bachmann, G., Ramiro, A. R. & Petersen-Mahrt, S. K. Estrogen directly activates AID transcription and function. J. Exp. Med. 206, 99\u2013111 (2009).","journal-title":"J. Exp. Med."},{"key":"503_CR55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molimm.2016.07.015","volume":"77","author":"BG Jones","year":"2016","unstructured":"Jones, B. G. et al. Binding of estrogen receptors to switch sites and regulatory elements in the immunoglobulin heavy chain locus of activated B cells suggests a direct influence of estrogen on antibody expression. Mol. Immunol. 77, 97\u2013102 (2016).","journal-title":"Mol. Immunol."},{"key":"503_CR56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/annrheumdis-2017-211555","volume":"77","author":"KF Baker","year":"2018","unstructured":"Baker, K. F. & Isaacs, J. D. Novel therapies for immune-mediated inflammatory diseases: what can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn\u2019s disease and ulcerative colitis? Ann. Rheum. Dis. 77, 175\u2013187 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"503_CR57","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrrheum.2016.61","volume":"12","author":"LA Joosten","year":"2016","unstructured":"Joosten, L. A., Abdollahi-Roodsaz, S., Dinarello, C. A., O\u2019Neill, L. & Netea, M. G. Toll-like receptors and chronic inflammation in rheumatic diseases: new developments. Nat. Rev. Rheumatol. 12, 344\u2013357 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"503_CR58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clim.2014.01.006","volume":"151","author":"NA Young","year":"2014","unstructured":"Young, N. A. et al. Estrogen modulation of endosome-associated toll-like receptor 8: an IFN\u03b1-independent mechanism of sex-bias in systemic lupus erythematosus. Clin. Immunol. 151, 66\u201377 (2014).","journal-title":"Clin. Immunol."},{"key":"503_CR59","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/imm.12263","volume":"142","author":"J Lee","year":"2014","unstructured":"Lee, J. et al. Oestrogen up-regulates interleukin-21 production by CD4+ T lymphocytes in patients with systemic lupus erythematosus. Immunology 142, 573\u2013580 (2014).","journal-title":"Immunology"},{"key":"503_CR60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/art.38187","volume":"66","author":"S Smith","year":"2014","unstructured":"Smith, S. et al. Estrogen receptor alpha regulates tripartite motif-containing protein 21 expression, contributing to dysregulated cytokine production in systemic lupus erythematosus. Arthritis Rheumatol. 66, 163\u2013172 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"503_CR61","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa176","author":"S Lee","year":"2020","unstructured":"Lee, S. et al. Interleukin-23 drives expansion of Thelper 17 cells through epigenetic regulation by signal transducer and activators of transcription 3 in lupus patients. Rheumatology https:\/\/doi.org\/10.1093\/rheumatology\/keaa176 (2020).","journal-title":"Rheumatology"},{"key":"503_CR62","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.4049\/jimmunol.1500315","volume":"195","author":"JL Scott","year":"2015","unstructured":"Scott, J. L. et al. Estrogen receptor alpha deficiency modulates TLR ligand-mediated PDC-TREM expression in plasmacytoid dendritic cells in lupus-prone mice. J. Immunol. 195, 5561\u20135571 (2015).","journal-title":"J. Immunol."},{"key":"503_CR63","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/rheumatology\/kew248","volume":"55","author":"L Xue","year":"2016","unstructured":"Xue, L. et al. Estrogen-induced expression of tumor necrosis factor-like weak inducer of apoptosis through ER\u03b1 accelerates the progression of lupus nephritis. Rheumatology 55, 1880\u20131888 (2016).","journal-title":"Rheumatology"},{"key":"503_CR64","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1440-1797.2011.01449.x","volume":"16","author":"J Lu","year":"2011","unstructured":"Lu, J. et al. Gene expression of TWEAK\/Fn14 and IP-10\/CXCR3 in glomerulus and tubulointerstitium of patients with lupus nephritis. Nephrology 16, 426\u2013432 (2011).","journal-title":"Nephrology"},{"key":"503_CR65","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaut.2006.12.003","volume":"27","author":"N Schwartz","year":"2006","unstructured":"Schwartz, N. et al. Urinary TWEAK and the activity of lupus nephritis. J. Autoimmun. 27, 242\u2013250 (2006).","journal-title":"J. Autoimmun."},{"key":"503_CR66","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","volume":"11","author":"E Lubberts","year":"2015","unstructured":"Lubberts, E. The IL-23-IL-17 axis in inflammatory arthritis. Nat. Rev. Rheumatol. 11, 415\u2013429 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"503_CR67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13075-015-0548-y","volume":"17","author":"A Andersson","year":"2015","unstructured":"Andersson, A. et al. Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis. Arthritis Res. Ther. 17, 32 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"503_CR68","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.4049\/jimmunol.1400806","volume":"194","author":"RY Chen","year":"2015","unstructured":"Chen, R. Y. et al. Estradiol inhibits Th17 cell differentiation through inhibition of ROR\u03b3T transcription by recruiting the ER\u03b1\/REA complex to estrogen response elements of the ROR\u03b3T promoter. J. Immunol. 194, 4019\u20134028 (2015).","journal-title":"J. Immunol."},{"key":"503_CR69","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jaci.2015.05.046","volume":"136","author":"DC Newcomb","year":"2015","unstructured":"Newcomb, D. C. et al. Estrogen and progesterone decrease let-7f microRNA expression and increase IL-23\/IL-23 receptor signaling and IL-17A production in patients with severe asthma. J. Allergy Clin. Immunol. 136, 1025\u20131034 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"503_CR70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clim.2018.02.006","volume":"190","author":"J Qin","year":"2018","unstructured":"Qin, J. et al. Estrogen receptor \u03b2 activation stimulates the development of experimental autoimmune thyroiditis through up-regulation of Th17-type responses. Clin. Immunol. 190, 41\u201352 (2018).","journal-title":"Clin. Immunol."},{"key":"503_CR71","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13075-018-1586-z","volume":"20","author":"C Engdahl","year":"2018","unstructured":"Engdahl, C. et al. Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: a potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women. Arthritis Res. Ther. 20, 84 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"503_CR72","volume":"7","author":"ML Zhu","year":"2016","unstructured":"Zhu, M. L. et al. Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator. Nat. Commun. 7, 11350 (2016).","journal-title":"Nat. Commun."},{"key":"503_CR73","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nri.2017.75","volume":"17","author":"L Lu","year":"2017","unstructured":"Lu, L., Barbi, J. & Pan, F. The regulation of immune tolerance by FOXP3. Nat. Rev. Immunol. 17, 703\u2013717 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"503_CR74","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1091\/mbc.E14-08-1323","volume":"26","author":"M Walecki","year":"2015","unstructured":"Walecki, M. et al. Androgen receptor modulates Foxp3 expression in CD4+CD25+Foxp3+regulatory T-cells. Mol. Biol. Cell 26, 2845\u20132857 (2015).","journal-title":"Mol. Biol. Cell"},{"key":"503_CR75","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1172\/JCI200113183","volume":"108","author":"NJ Olsen","year":"2001","unstructured":"Olsen, N. J., Gu, X. & Kovacs, W. J. Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development. J. Clin. Invest. 108, 1697\u20131704 (2001).","journal-title":"J. Clin. Invest."},{"key":"503_CR76","first-page":"813","volume":"28","author":"G Pongratz","year":"2010","unstructured":"Pongratz, G., Straub, R. H., Scholmerich, J., Fleck, M. & Harle, P. Serum BAFF strongly correlates with PsA activity in male patients only \u2014 is there a role for sex hormones? Clin. Exp. Rheumatol. 28, 813\u2013819 (2010).","journal-title":"Clin. Exp. Rheumatol."},{"key":"503_CR77","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04408-0","volume":"9","author":"AS Wilhelmson","year":"2018","unstructured":"Wilhelmson, A. S. et al. Testosterone is an endogenous regulator of BAFF and splenic B cell number. Nat. Commun. 9, 2067 (2018).","journal-title":"Nat. Commun."},{"key":"503_CR78","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2119\/molmed.2010.00172","volume":"17","author":"L Hill","year":"2011","unstructured":"Hill, L., Jeganathan, V., Chinnasamy, P., Grimaldi, C. & Diamond, B. Differential roles of estrogen receptors alpha and beta in control of B-cell maturation and selection. Mol. Med. 17, 211\u2013220 (2011).","journal-title":"Mol. Med."},{"key":"503_CR79","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s10528-016-9752-y","volume":"54","author":"MN Drehmer","year":"2016","unstructured":"Drehmer, M. N., Suterio, D. G., Muniz, Y. C., de Souza, I. R. & Lofgren, S. E. BAFF expression is modulated by female hormones in human immune cells. Biochem. Genet. 54, 722\u2013730 (2016).","journal-title":"Biochem. Genet."},{"key":"503_CR80","unstructured":"U.S. National Library of Medicine. Entrez Gene https:\/\/www.ncbi.nlm.nih.gov\/gene\/5770 (2019)."},{"key":"503_CR81","doi-asserted-by":"crossref","first-page":"9887","DOI":"10.1073\/pnas.1402468111","volume":"111","author":"HT Kissick","year":"2014","unstructured":"Kissick, H. T. et al. Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation. Proc. Natl Acad. Sci. USA 111, 9887\u20139892 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"503_CR82","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/08916934.2015.1030613","volume":"48","author":"AH Wong","year":"2015","unstructured":"Wong, A. H., Agrawal, N. & Hughes, G. C. Altered IgG autoantibody levels and CD4+ T cell subsets in lupus-prone Nba2 mice lacking the nuclear progesterone receptor. Autoimmunity 48, 389\u2013401 (2015).","journal-title":"Autoimmunity"},{"key":"503_CR83","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.4049\/jimmunol.0803915","volume":"183","author":"S Pauklin","year":"2009","unstructured":"Pauklin, S. & Petersen-Mahrt, S. K. Progesterone inhibits activation-induced deaminase by binding to the promoter. J. Immunol. 183, 1238\u20131244 (2009).","journal-title":"J. Immunol."},{"key":"503_CR84","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3389\/fimmu.2016.00565","volume":"7","author":"S Giaglis","year":"2016","unstructured":"Giaglis, S. et al. Multimodal regulation of NET formation in pregnancy: progesterone antagonizes the pro-NETotic effect of estrogen and G-CSF. Front. Immunol. 7, 565 (2016).","journal-title":"Front. Immunol."},{"key":"503_CR85","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1084\/jem.180.6.2359","volume":"180","author":"JD Taurog","year":"1994","unstructured":"Taurog, J. D. et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180, 2359\u20132364 (1994).","journal-title":"J. Exp. Med."},{"key":"503_CR86","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aar7201","volume":"359","author":"S Manfredo Vieira","year":"2018","unstructured":"Manfredo Vieira, S. et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359, 1156\u20131161 (2018).","journal-title":"Science"},{"key":"503_CR87","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.autrev.2016.07.012","volume":"15","author":"O Shamriz","year":"2016","unstructured":"Shamriz, O. et al. Microbiota at the crossroads of autoimmunity. Autoimmun. Rev. 15, 859\u2013869 (2016).","journal-title":"Autoimmun. Rev."},{"key":"503_CR88","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri.2016.36","volume":"16","author":"T Tanoue","year":"2016","unstructured":"Tanoue, T., Atarashi, K. & Honda, K. Development and maintenance of intestinal regulatory T cells. Nat. Rev. Immunol. 16, 295\u2013309 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"503_CR89","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2018.05.008","volume":"92","author":"L Rizzetto","year":"2018","unstructured":"Rizzetto, L., Fava, F., Tuohy, K. M. & Selmi, C. Connecting the immune system, systemic chronic inflammation and the gut microbiome: the role of sex. J. Autoimmun. 92, 12\u201334 (2018).","journal-title":"J. Autoimmun."},{"key":"503_CR90","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00281-018-0716-7","volume":"41","author":"R Vemuri","year":"2019","unstructured":"Vemuri, R. et al. The microgenderome revealed: sex differences in bidirectional interactions between the microbiota, hormones, immunity and disease susceptibility. Semin. Immunopathol. 41, 265\u2013275 (2019).","journal-title":"Semin. Immunopathol."},{"key":"503_CR91","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nature13178","volume":"509","author":"T Ding","year":"2014","unstructured":"Ding, T. & Schloss, P. D. Dynamics and associations of microbial community types across the human body. Nature 509, 357\u2013360 (2014).","journal-title":"Nature"},{"key":"503_CR92","doi-asserted-by":"crossref","first-page":"100815","DOI":"10.1016\/j.yfrne.2019.100815","volume":"56","author":"M Jaggar","year":"2019","unstructured":"Jaggar, M., Rea, K., Spicak, S., Dinan, T. G. & Cryan, J. F. You\u2019ve got male: sex and the microbiota-gut brain axis across the lifespan. Front. Neuroendocrinol. 56, 100815 (2019).","journal-title":"Front. Neuroendocrinol."},{"key":"503_CR93","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1128\/AEM.01182-13","volume":"79","author":"R Menon","year":"2013","unstructured":"Menon, R. et al. Diet complexity and estrogen receptor beta status affect the composition of the murine intestinal microbiota. Appl. Env. Microbiol. 79, 5763\u20135773 (2013).","journal-title":"Appl. Env. Microbiol."},{"key":"503_CR94","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000444066","volume":"93","author":"A Andoh","year":"2016","unstructured":"Andoh, A. Physiological role of gut microbiota for maintaining human health. Digestion 93, 176\u2013181 (2016).","journal-title":"Digestion"},{"key":"503_CR95","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2017.06.007","volume":"310","author":"G Benedek","year":"2017","unstructured":"Benedek, G. et al. Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells. J. Neuroimmunol. 310, 51\u201359 (2017).","journal-title":"J. Neuroimmunol."},{"key":"503_CR96","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.1233521","volume":"339","author":"JG Markle","year":"2013","unstructured":"Markle, J. G. et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339, 1084\u20131088 (2013).","journal-title":"Science"},{"key":"503_CR97","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.immuni.2013.08.013","volume":"39","author":"L Yurkovetskiy","year":"2013","unstructured":"Yurkovetskiy, L. et al. Gender bias in autoimmunity is influenced by microbiota. Immunity 39, 400\u2013412 (2013).","journal-title":"Immunity"},{"key":"503_CR98","volume":"7","author":"A Gomez","year":"2012","unstructured":"Gomez, A. et al. Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS ONE 7, e36095 (2012).","journal-title":"PLoS ONE"},{"key":"503_CR99","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000523","volume":"3","author":"M Caprioli","year":"2017","unstructured":"Caprioli, M., Carrara, G., Sakellariou, G., Silvagni, E. & Scire, C. A. Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology. RMD Open 3, e000523 (2017).","journal-title":"RMD Open"},{"key":"503_CR100","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015052","volume":"98","author":"S Tenti","year":"2019","unstructured":"Tenti, S., Giordano, N., Cutolo, M., Giannini, F. & Fioravanti, A. Primary antiphospholipid syndrome during aromatase inhibitors therapy: a case report and review of the literature. Medicine 98, e15052 (2019).","journal-title":"Medicine"},{"key":"503_CR101","first-page":"593493","volume":"2013","author":"AT Masi","year":"2013","unstructured":"Masi, A. T. et al. Lower serum androstenedione levels in pre-rheumatoid arthritis versus normal control women: correlations with lower serum cortisol levels. Autoimmune. Dis. 2013, 593493 (2013).","journal-title":"Autoimmune. Dis."},{"key":"503_CR102","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/ard.57.5.281","volume":"57","author":"R Heikkila","year":"1998","unstructured":"Heikkila, R. et al. Serum androgen-anabolic hormones and the risk of rheumatoid arthritis. Ann. Rheum. Dis. 57, 281\u2013285 (1998).","journal-title":"Ann. Rheum. Dis."},{"key":"503_CR103","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/annrheumdis-2012-202781","volume":"73","author":"M Pikwer","year":"2014","unstructured":"Pikwer, M. et al. Association between testosterone levels and risk of future rheumatoid arthritis in men: a population-based case-control study. Ann. Rheum. Dis. 73, 573\u2013579 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"503_CR104","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.semarthrit.2019.07.007","volume":"50","author":"J Ciaffi","year":"2020","unstructured":"Ciaffi, J., van Leeuwen, N. M., Schoones, J. W., Huizinga, T. W. J. & de Vries-Bouwstra, J. K. Sex hormones and sex hormone-targeting therapies in systemic sclerosis: a systematic literature review. Semin. Arthritis Rheum. 50, 140\u2013148 (2020).","journal-title":"Semin. Arthritis Rheum."},{"key":"503_CR105","first-page":"50","volume":"36","author":"C Campochiaro","year":"2018","unstructured":"Campochiaro, C., Host, L. V., Ong, V. H. & Denton, C. P. Development of systemic sclerosis in transgender females: a case series and review of the literature. Clin. Exp. Rheumatol. 36, 50\u201352 (2018).","journal-title":"Clin. Exp. Rheumatol."},{"key":"503_CR106","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1007\/s10067-016-3330-x","volume":"35","author":"J Baillargeon","year":"2016","unstructured":"Baillargeon, J. et al. Hypogonadism and the risk of rheumatic autoimmune disease. Clin. Rheumatol. 35, 2983\u20132987 (2016).","journal-title":"Clin. Rheumatol."},{"key":"503_CR107","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/08916934.2014.968918","volume":"48","author":"OO Seminog","year":"2015","unstructured":"Seminog, O. O., Seminog, A. B., Yeates, D. & Goldacre, M. J. Associations between Klinefelter\u2019s syndrome and autoimmune diseases: English national record linkage studies. Autoimmunity 48, 125\u2013128 (2015).","journal-title":"Autoimmunity"},{"key":"503_CR108","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10067-017-3873-5","volume":"37","author":"J Pakpoor","year":"2018","unstructured":"Pakpoor, J., Goldacre, R. & Goldacre, M. J. Associations between clinically diagnosed testicular hypofunction and systemic lupus erythematosus: a record linkage study. Clin. Rheumatol. 37, 559\u2013562 (2018).","journal-title":"Clin. Rheumatol."},{"key":"503_CR109","doi-asserted-by":"crossref","first-page":"A493","DOI":"10.1016\/j.autrev.2011.11.027","volume":"11","author":"C Chighizola","year":"2012","unstructured":"Chighizola, C. & Meroni, P. L. The role of environmental estrogens and autoimmunity. Autoimmun. Rev. 11, A493\u2013A501 (2012).","journal-title":"Autoimmun. Rev."},{"key":"503_CR110","doi-asserted-by":"crossref","first-page":"110680","DOI":"10.1016\/j.mce.2019.110680","volume":"502","author":"GR Warner","year":"2019","unstructured":"Warner, G. R., Mourikes, V. E., Neff, A. M., Brehm, E. & Flaws, J. A. Mechanisms of action of agrochemicals acting as endocrine disrupting chemicals. Mol. Cell Endocrinol. 502, 110680 (2019).","journal-title":"Mol. Cell Endocrinol."},{"key":"503_CR111","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/08916934.2018.1551374","volume":"51","author":"G Aljadeff","year":"2018","unstructured":"Aljadeff, G., Longhi, E. & Shoenfeld, Y. Bisphenol A: a notorious player in the mosaic of autoimmunity. Autoimmunity 51, 370\u2013377 (2018).","journal-title":"Autoimmunity"},{"key":"503_CR112","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1210\/jc.2018-02312","volume":"104","author":"NA Jayasuriya","year":"2019","unstructured":"Jayasuriya, N. A. et al. A lower maternal cortisol-to-cortisone ratio precedes clinical diagnosis of preterm and term preeclampsia by many weeks. J. Clin. Endocrinol. Metab. 104, 2355\u20132366 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"503_CR113","doi-asserted-by":"crossref","first-page":"101321","DOI":"10.1016\/j.beem.2019.101321","volume":"33","author":"VV Borba","year":"2019","unstructured":"Borba, V. V., Zandman-Goddard, G. & Shoenfeld, Y. Exacerbations of autoimmune diseases during pregnancy and postpartum. Best Pract. Res. Clin. Endocrinol. Metab. 33, 101321 (2019).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"503_CR114","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/rheumatology\/key047","volume":"57","author":"K Ursin","year":"2018","unstructured":"Ursin, K., Lydersen, S., Skomsvoll, J. F. & Wallenius, M. Disease activity during and after pregnancy in women with axial spondyloarthritis: a prospective multicentre study. Rheumatology 57, 1064\u20131071 (2018).","journal-title":"Rheumatology"},{"key":"503_CR115","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/acr.23143","volume":"69","author":"H Ince-Askan","year":"2017","unstructured":"Ince-Askan, H., Hazes, J. M. W. & Dolhain, R. Identifying clinical factors associated with low disease activity and remission of rheumatoid arthritis during pregnancy. Arthritis Care Res. 69, 1297\u20131303 (2017).","journal-title":"Arthritis Care Res."},{"key":"503_CR116","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/rheumatology\/key053","volume":"57","author":"A Zbinden","year":"2018","unstructured":"Zbinden, A., van den Brandt, S., Ostensen, M., Villiger, P. M. & Forger, F. Risk for adverse pregnancy outcome in axial spondyloarthritis and rheumatoid arthritis: disease activity matters. Rheumatology 57, 1235\u20131242 (2018).","journal-title":"Rheumatology"},{"key":"503_CR117","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13075-020-2139-9","volume":"22","author":"J Davis-Porada","year":"2020","unstructured":"Davis-Porada, J. et al. Low frequency of flares during pregnancy and post-partum in stable lupus patients. Arthritis Res. Ther. 22, 52 (2020).","journal-title":"Arthritis Res. Ther."},{"key":"503_CR118","first-page":"2413637","volume":"2018","author":"D Chen","year":"2018","unstructured":"Chen, D. et al. Fetal and maternal outcomes of planned pregnancy in patients with systemic lupus erythematosus: a retrospective multicenter study. J. Immunol. Res. 2018, 2413637 (2018).","journal-title":"J. Immunol. Res."},{"key":"503_CR119","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/art.22510","volume":"56","author":"KH Costenbader","year":"2007","unstructured":"Costenbader, K. H., Feskanich, D., Stampfer, M. J. & Karlson, E. W. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum. 56, 1251\u20131262 (2007).","journal-title":"Arthritis Rheum."},{"key":"503_CR120","doi-asserted-by":"crossref","first-page":"A430","DOI":"10.1016\/j.autrev.2011.11.006","volume":"11","author":"LR Sammaritano","year":"2012","unstructured":"Sammaritano, L. R. Menopause in patients with autoimmune diseases. Autoimmun. Rev. 11, A430\u2013A436 (2012).","journal-title":"Autoimmun. Rev."},{"key":"503_CR121","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3899\/jrheum.131234","volume":"41","author":"EC Pfeifer","year":"2014","unstructured":"Pfeifer, E. C., Crowson, C. S., Amin, S., Gabriel, S. E. & Matteson, E. L. The influence of early menopause on cardiovascular risk in women with rheumatoid arthritis. J. Rheumatol. 41, 1270\u20131275 (2014).","journal-title":"J. Rheumatol."},{"key":"503_CR122","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/acr.22494","volume":"67","author":"LE Wong","year":"2015","unstructured":"Wong, L. E. et al. Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the Canadian Early Arthritis Cohort. Arthritis Care Res. 67, 616\u2013623 (2015).","journal-title":"Arthritis Care Res."},{"key":"503_CR123","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bpobgyn.2019.05.003","volume":"60","author":"G Benagiano","year":"2019","unstructured":"Benagiano, G., Benagiano, M., Bianchi, P., D\u2019Elios, M. M. & Brosens, I. Contraception in autoimmune diseases. Best Pract. Res. Clin. Obstet. Gynaecol. 60, 111\u2013123 (2019).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"503_CR124","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","volume":"142","author":"JP Buyon","year":"2005","unstructured":"Buyon, J. P. et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann. Intern. Med. 142, 953\u2013962 (2005).","journal-title":"Ann. Intern. Med."},{"key":"503_CR125","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/acr.20275","volume":"62","author":"JA Roman-Blas","year":"2010","unstructured":"Roman-Blas, J. A., Castaneda, S., Cutolo, M. & Herrero-Beaumont, G. Efficacy and safety of a selective estrogen receptor \u03b2 agonist, ERB-041, in patients with rheumatoid arthritis: a 12-week, randomized, placebo-controlled, phase II study. Arthritis Care Res. 62, 1588\u20131593 (2010).","journal-title":"Arthritis Care Res."},{"key":"503_CR126","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/art.27196","volume":"62","author":"RF van Vollenhoven","year":"2010","unstructured":"van Vollenhoven, R. F. et al. The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine. Arthritis Rheum. 62, 351\u2013358 (2010).","journal-title":"Arthritis Rheum."},{"key":"503_CR127","first-page":"797","volume":"35","author":"NI Abdou","year":"2008","unstructured":"Abdou, N. I., Rider, V., Greenwell, C., Li, X. & Kimler, B. F. Fulvestrant (Faslodex), an estrogen selective receptor downregulator, in therapy of women with systemic lupus erythematosus. clinical, serologic, bone density, and T cell activation marker studies: a double-blind placebo-controlled trial. J. Rheumatol. 35, 797 (2008).","journal-title":"J. Rheumatol."},{"key":"503_CR128","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.3390\/ijms20235867","volume":"20","author":"G Adami","year":"2019","unstructured":"Adami, G. et al. Osteoporosis in rheumatic diseases. Int. J. Mol. Sci. 20, 5867 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"503_CR129","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/ard.2010.135061","volume":"69","author":"G Schett","year":"2010","unstructured":"Schett, G., Saag, K. G. & Bijlsma, J. W. From bone biology to clinical outcome: state of the art and future perspectives. Ann. Rheum. Dis. 69, 1415\u20131419 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"503_CR130","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14740338.2015.1014799","volume":"14","author":"AJ Ellis","year":"2015","unstructured":"Ellis, A. J., Hendrick, V. M., Williams, R. & Komm, B. S. Selective estrogen receptor modulators in clinical practice: a safety overview. Expert Opin. Drug Saf. 14, 921\u2013934 (2015).","journal-title":"Expert Opin. Drug Saf."},{"key":"503_CR131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/JOE-17-0372","volume":"236","author":"A Andersson","year":"2018","unstructured":"Andersson, A. et al. Roles of activating functions 1 and 2 of estrogen receptor alpha in lymphopoiesis. J. Endocrinol. 236, 99\u2013109 (2018).","journal-title":"J. Endocrinol."},{"key":"503_CR132","doi-asserted-by":"crossref","first-page":"E912","DOI":"10.1152\/ajpendo.00488.2015","volume":"310","author":"AE Borjesson","year":"2016","unstructured":"Borjesson, A. E. et al. SERMs have substance-specific effects on bone, and these effects are mediated via ER\u03b1AF-1 in female mice. Am. J. Physiol. Endocrinol. Metab. 310, E912\u2013E918 (2016).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"503_CR133","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1073\/pnas.1100454108","volume":"108","author":"AE B\u00f6rjesson","year":"2011","unstructured":"B\u00f6rjesson, A. E. et al. Roles of transactivating functions 1 and 2 of estrogen receptor-\u03b1 in bone. Proc. Natl Acad. Sci. USA 108, 6288\u20136293 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"503_CR134","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/iid3.37","volume":"2","author":"AI Bernardi","year":"2014","unstructured":"Bernardi, A. I. et al. Effects of lasofoxifene and bazedoxifene on B cell development and function. Immun. Inflamm. Dis. 2, 214\u2013225 (2014).","journal-title":"Immun. Inflamm. Dis."},{"key":"503_CR135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.maturitas.2013.06.003","volume":"76","author":"S Mirkin","year":"2013","unstructured":"Mirkin, S. & Komm, B. S. Tissue-selective estrogen complexes for postmenopausal women. Maturitas 76, 213\u2013220 (2013).","journal-title":"Maturitas"},{"key":"503_CR136","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.imbio.2017.05.013","volume":"222","author":"J Nordqvist","year":"2017","unstructured":"Nordqvist, J., Bernardi, A., Islander, U. & Carlsten, H. Effects of a tissue-selective estrogen complex on B lymphopoiesis and B cell function. Immunobiology 222, 918\u2013923 (2017).","journal-title":"Immunobiology"},{"key":"503_CR137","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1210\/en.2015-1820","volume":"157","author":"A Andersson","year":"2016","unstructured":"Andersson, A. et al. Suppression of experimental arthritis and associated bone loss by a tissue-selective estrogen complex. Endocrinology 157, 1013\u20131020 (2016).","journal-title":"Endocrinology"},{"key":"503_CR138","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.semarthrit.2013.04.008","volume":"43","author":"RH Straub","year":"2013","unstructured":"Straub, R. H., Bijlsma, J. W., Masi, A. & Cutolo, M. Role of neuroendocrine and neuroimmune mechanisms in chronic inflammatory rheumatic diseases \u2014 the 10-year update. Semin. Arthritis Rheum. 43, 392\u2013404 (2013).","journal-title":"Semin. Arthritis Rheum."},{"key":"503_CR139","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000175839","volume":"37","author":"S Arver","year":"2009","unstructured":"Arver, S. & Lehtihet, M. Current guidelines for the diagnosis of testosterone deficiency. Front. Horm. Res. 37, 5\u201320 (2009).","journal-title":"Front. Horm. Res."},{"key":"503_CR140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.1780340102","volume":"34","author":"M Cutolo","year":"1991","unstructured":"Cutolo, M., Balleari, E., Giusti, M., Intra, E. & Accardo, S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum. 34, 1\u20135 (1991).","journal-title":"Arthritis Rheum."},{"key":"503_CR141","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/ard.55.11.811","volume":"55","author":"A Booji","year":"1996","unstructured":"Booji, A. et al. Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Ann. Rheum. Dis. 55, 811\u2013815 (1996).","journal-title":"Ann. Rheum. Dis."},{"key":"503_CR142","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/and.12452","volume":"48","author":"F Saad","year":"2016","unstructured":"Saad, F., Haider, A. & Gooren, L. Hypogonadal men with psoriasis benefit from long-term testosterone replacement therapy \u2014 a series of 15 case reports. Andrologia 48, 341\u2013346 (2016).","journal-title":"Andrologia"},{"key":"503_CR143","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/03009742.2011.580000","volume":"40","author":"P Porola","year":"2011","unstructured":"Porola, P., Straub, R. H., Virkki, L. M., Konttinen, Y. T. & Nordstrom, D. C. Failure of oral DHEA treatment to increase local salivary androgen outputs of female patients with Sjogren\u2019s syndrome. Scand. J. Rheumatol. 40, 387\u2013390 (2011).","journal-title":"Scand. J. Rheumatol."},{"key":"503_CR144","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/ard.42.2.155","volume":"42","author":"RA Hazelton","year":"1983","unstructured":"Hazelton, R. A., McCruden, A. B., Sturrock, R. D. & Stimson, W. H. Hormonal manipulation of the immune response in systemic lupus erythematosus: a drug trial of an anabolic steroid, 19-nortestosterone. Ann. Rheum. Dis. 42, 155\u2013157 (1983).","journal-title":"Ann. Rheum. Dis."},{"key":"503_CR145","first-page":"547","volume":"19","author":"RG Lahita","year":"1992","unstructured":"Lahita, R. G., Cheng, C. Y., Monder, C. & Bardin, C. W. Experience with 19-nortestosterone in the therapy of systemic lupus erythematosus: worsened disease after treatment with 19-nortestosterone in men and lack of improvement in women. J. Rheumatol. 19, 547\u2013555 (1992).","journal-title":"J. Rheumatol."},{"key":"503_CR146","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00000441-199510000-00006","volume":"310","author":"NJ Olsen","year":"1995","unstructured":"Olsen, N. J. & Kovacs, W. J. Case report: testosterone treatment of systemic lupus erythematosus in a patient with Klinefelter\u2019s syndrome. Am. J. Med. Sci. 310, 158\u2013160 (1995).","journal-title":"Am. J. Med. Sci."},{"key":"503_CR147","first-page":"CD005114","volume":"4","author":"D Crosbie","year":"2007","unstructured":"Crosbie, D., Black, C., McIntyre, L., Royle, P. L. & Thomas, S. Dehydroepiandrosterone for systemic lupus erythematosus. Cochrane Database Syst. Rev. 4, CD005114 (2007).","journal-title":"Cochrane Database Syst. Rev."},{"key":"503_CR148","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.semarthrit.2010.03.005","volume":"40","author":"P Letchumanan","year":"2011","unstructured":"Letchumanan, P. & Thumboo, J. Danazol in the treatment of systemic lupus erythematosus: a qualitative systematic review. Semin. Arthritis Rheum. 40, 298\u2013306 (2011).","journal-title":"Semin. Arthritis Rheum."},{"key":"503_CR149","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780250603","volume":"25","author":"P Jungers","year":"1982","unstructured":"Jungers, P. et al. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum. 25, 618\u2013623 (1982).","journal-title":"Arthritis Rheum."},{"key":"503_CR150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2010.08.012","volume":"83","author":"N Chabbert-Buffet","year":"2011","unstructured":"Chabbert-Buffet, N. et al. Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients. Contraception 83, 229\u2013237 (2011).","journal-title":"Contraception"},{"key":"503_CR151","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1515\/REVNEURO.1993.4.3.223","volume":"4","author":"C Rivier","year":"1993","unstructured":"Rivier, C. Neuroendocrine effects of cytokines in the rat. Rev. Neurosci. 4, 223\u2013237 (1993).","journal-title":"Rev. Neurosci."},{"key":"503_CR152","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1210\/endo-124-5-2105","volume":"124","author":"C Rivier","year":"1989","unstructured":"Rivier, C. & Vale, W. In the rat, interleukin-1 alpha acts at the level of the brain and the gonads to interfere with gonadotropin and sex steroid secretion. Endocrinology 124, 2105\u20132109 (1989).","journal-title":"Endocrinology"},{"key":"503_CR153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-0172(84)90005-2","volume":"14","author":"AT Masi","year":"1984","unstructured":"Masi, A. T., Josipovic, D. B. & Jefferson, W. E. Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion. Semin. Arthritis Rheum. 14, 1\u201323 (1984).","journal-title":"Semin. Arthritis Rheum."},{"key":"503_CR154","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/art.1780300301","volume":"30","author":"RG Lahita","year":"1987","unstructured":"Lahita, R. G., Bradlow, H. L., Ginzler, E., Pang, S. & New, M. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum. 30, 241\u2013248 (1987).","journal-title":"Arthritis Rheum."},{"key":"503_CR155","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/art.1780311015","volume":"31","author":"M Cutolo","year":"1988","unstructured":"Cutolo, M., Balleari, E., Giusti, M., Monachesi, M. & Accardo, S. Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum. 31, 1314\u20131317 (1988).","journal-title":"Arthritis Rheum."},{"key":"503_CR156","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0167-5699(98)01422-4","volume":"20","author":"JW Bijlsma","year":"1999","unstructured":"Bijlsma, J. W., Cutolo, M., Masi, A. T. & Chikanza, I. C. The neuroendocrine immune basis of rheumatic diseases. Immunol. Today 20, 298\u2013301 (1999).","journal-title":"Immunol. Today"},{"key":"503_CR157","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1529-0131(200103)44:3<493::AID-ANR95>3.0.CO;2-U","volume":"44","author":"RH Straub","year":"2001","unstructured":"Straub, R. H. & Cutolo, M. Involvement of the hypothalamic\u2013pituitary\u2013adrenal\/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum. 44, 493\u2013507 (2001).","journal-title":"Arthritis Rheum."},{"key":"503_CR158","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1677\/joe.0.1640161","volume":"164","author":"M Schmidt","year":"2000","unstructured":"Schmidt, M., Kreutz, M., L\u00f6ffler, G., Sch\u00f6lmerich, J. & Straub, R. H. Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J. Endocrinol. 164, 161\u2013169 (2000).","journal-title":"J. Endocrinol."},{"key":"503_CR159","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/art.1780221106","volume":"22","author":"RG Lahita","year":"1979","unstructured":"Lahita, R. G., Bradlow, H. L., Kunkel, H. G. & Fishman, J. Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum. 22, 1195\u20131198 (1979).","journal-title":"Arthritis Rheum."},{"key":"503_CR160","first-page":"489","volume":"31","author":"C Weidler","year":"2004","unstructured":"Weidler, C. et al. Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens. J. Rheumatol. 31, 489\u2013494 (2004).","journal-title":"J. Rheumatol."},{"key":"503_CR161","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1749-6632.2002.tb04213.x","volume":"966","author":"M Herrmann","year":"2002","unstructured":"Herrmann, M., Sch\u00f6lmerich, J. & Straub, R. H. Influence of cytokines and growth factors on distinct steroidogenic enzymes in vitro: a short tabular data collection. Ann. N. Y. Acad. Sci. 966, 166\u2013186 (2002).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"503_CR162","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/art.21826","volume":"54","author":"RH Straub","year":"2006","unstructured":"Straub, R. H. et al. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study. Arthritis Rheum. 54, 1778\u20131785 (2006).","journal-title":"Arthritis Rheum."},{"key":"503_CR163","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2796.2010.02218.x","volume":"267","author":"RH Straub","year":"2010","unstructured":"Straub, R. H., Cutolo, M., Buttgereit, F. & Pongratz, G. Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J. Intern. Med. 267, 543\u2013560 (2010).","journal-title":"J. Intern. Med."},{"key":"503_CR164","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrrheum.2017.172","volume":"13","author":"RH Straub","year":"2017","unstructured":"Straub, R. H. The brain and immune system prompt energy shortage in chronic inflammation and ageing. Nat. Rev. Rheumatol. 13, 743\u2013751 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"503_CR165","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.fertnstert.2008.08.123","volume":"91","author":"H Browne","year":"2009","unstructured":"Browne, H. et al. Assessment of ovarian function with anti-M\u00fcllerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplant. Fertil. Steril. 91, 1529\u20131532 (2009).","journal-title":"Fertil. Steril."},{"key":"503_CR166","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/acr.22013","volume":"65","author":"J Brouwer","year":"2013","unstructured":"Brouwer, J., Laven, J. S., Hazes, J. M., Schipper, I. & Dolhain, R. J. Levels of serum anti-M\u00fcllerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis. Arthritis Care Res. 65, 1534\u20131538 (2013).","journal-title":"Arthritis Care Res."},{"key":"503_CR167","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/acr.20605","volume":"63","author":"ME Clowse","year":"2011","unstructured":"Clowse, M. E. et al. Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener\u2019s). Arthritis Care Res. 63, 1777\u20131781 (2011).","journal-title":"Arthritis Care Res."},{"key":"503_CR168","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10067-014-2680-5","volume":"34","author":"AR Mont\u2019Alverne","year":"2015","unstructured":"Mont\u2019Alverne, A. R. et al. Diminished ovarian reserve in Beh\u00e7et\u2019s disease patients. Clin. Rheumatol. 34, 179\u2013183 (2015).","journal-title":"Clin. Rheumatol."},{"key":"503_CR169","first-page":"44","volume":"33","author":"FH de Souza","year":"2015","unstructured":"de Souza, F. H. et al. Reduction of ovarian reserve in adult patients with dermatomyositis. Clin. Exp. Rheumatol. 33, 44\u201349 (2015).","journal-title":"Clin. Exp. Rheumatol."},{"key":"503_CR170","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/rheumatology\/kev124","volume":"54","author":"M Henes","year":"2015","unstructured":"Henes, M. et al. Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Beh\u00e7et\u2019s disease and spondyloarthritis on anti-M\u00fcllerian hormone levels. Rheumatology 54, 1709\u20131712 (2015).","journal-title":"Rheumatology"},{"key":"503_CR171","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s10067-015-3064-1","volume":"34","author":"FH de Souza","year":"2015","unstructured":"de Souza, F. H. et al. Reduced ovarian reserve in patients with adult polymyositis. Clin. Rheumatol. 34, 1795\u20131799 (2015).","journal-title":"Clin. Rheumatol."},{"key":"503_CR172","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.1780360103","volume":"36","author":"JL Nelson","year":"1993","unstructured":"Nelson, J. L. et al. Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum. 36, 7\u201314 (1993).","journal-title":"Arthritis Rheum."},{"key":"503_CR173","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/acr.20323","volume":"62","author":"CA Silva","year":"2010","unstructured":"Silva, C. A., Bonfa, E. & Ostensen, M. Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs. Arthritis Care Res. 62, 1682\u20131690 (2010).","journal-title":"Arthritis Care Res."},{"key":"503_CR174","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/BOR.0000000000000058","volume":"26","author":"M Provost","year":"2014","unstructured":"Provost, M., Eaton, J. L. & Clowse, M. E. Fertility and infertility in rheumatoid arthritis. Curr. Opin. Rheumatol. 26, 308\u2013314 (2014).","journal-title":"Curr. Opin. Rheumatol."},{"key":"503_CR175","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrrheum.2014.113","volume":"10","author":"M Ostensen","year":"2014","unstructured":"Ostensen, M. Rheumatoid arthritis: the effect of RA and medication on female fertility. Nat. Rev. Rheumatol. 10, 518\u2013519 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"503_CR176","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1136\/annrheumdis-2014-205383","volume":"74","author":"J Brouwer","year":"2015","unstructured":"Brouwer, J., Hazes, J. M., Laven, J. S. & Dolhain, R. J. Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann. Rheum. Dis. 74, 1836\u20131841 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"503_CR177","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X18759898","author":"K Chatzimeletiou","year":"2018","unstructured":"Chatzimeletiou, K. et al. Fertility potential in a man with ankylosing spondylitis as revealed by semen analysis by light, electron and fluorescence microscopy. SAGE Open Med. Case Rep. https:\/\/doi.org\/10.1177\/2050313X18759898 (2018).","journal-title":"SAGE Open Med. Case Rep."},{"key":"503_CR178","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3899\/jrheum.140416","volume":"42","author":"D Fan","year":"2015","unstructured":"Fan, D. et al. Male sexual dysfunction and ankylosing spondylitis: a systematic review and metaanalysis. J. Rheumatol. 42, 252\u2013257 (2015).","journal-title":"J. Rheumatol."},{"key":"503_CR179","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11926-016-0597-5","volume":"18","author":"VK Jaeger","year":"2016","unstructured":"Jaeger, V. K. & Walker, U. A. Erectile dysfunction in systemic sclerosis. Curr. Rheumatol. Rep. 18, 49 (2016).","journal-title":"Curr. Rheumatol. Rep."},{"key":"503_CR180","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00296-019-04365-x","volume":"39","author":"L Luo","year":"2019","unstructured":"Luo, L. et al. Gout is associated with elevated risk of erectile dysfunction: a systematic review and meta-analysis. Rheumatol. Int. 39, 1527\u20131535 (2019).","journal-title":"Rheumatol. Int."},{"key":"503_CR181","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1590\/S0100-879X2008001200016","volume":"41","author":"AJ Moraes","year":"2008","unstructured":"Moraes, A. J. et al. Minor sperm abnormalities in young male post-pubertal patients with juvenile dermatomyositis. Braz. J. Med. Biol. Res. 41, 1142\u20131147 (2008).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"503_CR182","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10067-012-2083-4","volume":"32","author":"CN Rabelo-Junior","year":"2013","unstructured":"Rabelo-Junior, C. N. et al. Penile alterations with severe sperm abnormalities in antiphospholipid syndrome associated with systemic lupus erythematosus. Clin. Rheumatol. 32, 109\u2013113 (2013).","journal-title":"Clin. Rheumatol."},{"key":"503_CR183","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/art.22660","volume":"56","author":"PM Soares","year":"2007","unstructured":"Soares, P. M. et al. Gonad evaluation in male systemic lupus erythematosus. Arthritis Rheum. 56, 2352\u20132361 (2007).","journal-title":"Arthritis Rheum."},{"key":"503_CR184","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00296-017-3858-3","volume":"38","author":"A Taylan","year":"2018","unstructured":"Taylan, A. & Birlik, M. Parenchymal neuro-Beh\u00e7et disease with erectile dysfunction and micturition disturbances: case report and literature review. Rheumatol. Int. 38, 149\u2013152 (2018).","journal-title":"Rheumatol. Int."},{"key":"503_CR185","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1136\/ard.2009.127423","volume":"69","author":"PM Villiger","year":"2010","unstructured":"Villiger, P. M. et al. Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis. Ann. Rheum. Dis. 69, 1842\u20131844 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"503_CR186","first-page":"765","volume":"30","author":"R Puchner","year":"2012","unstructured":"Puchner, R., Danninger, K., Puchner, A. & Pieringer, H. Impact of TNF-blocking agents on male sperm characteristics and pregnancy outcomes in fathers exposed to TNF-blocking agents at time of conception. Clin. Exp. Rheumatol. 30, 765\u2013767 (2012).","journal-title":"Clin. Exp. Rheumatol."},{"key":"503_CR187","first-page":"37","volume":"2016","author":"RH Straub","year":"2016","unstructured":"Straub, R. H. & Schradin, C. Chronic inflammatory systemic diseases: an evolutionary trade-off between acutely beneficial but chronically harmful programs. Evol. Med. Public. Health 2016, 37\u201351 (2016).","journal-title":"Evol. Med. Public. Health"},{"key":"503_CR188","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/art.23930","volume":"59","author":"JF Simard","year":"2008","unstructured":"Simard, J. F. et al. Perinatal factors and adult-onset lupus. Arthritis Rheum. 59, 1155\u20131161 (2008).","journal-title":"Arthritis Rheum."},{"key":"503_CR189","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3899\/jrheum.090002","volume":"36","author":"CJ Ulff-Moller","year":"2009","unstructured":"Ulff-Moller, C. J., Jorgensen, K. T., Pedersen, B. V., Nielsen, N. M. & Frisch, M. Reproductive factors and risk of systemic lupus erythematosus: nationwide cohort study in Denmark. J. Rheumatol. 36, 1903\u20131909 (2009).","journal-title":"J. Rheumatol."},{"key":"503_CR190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104303","volume":"9","author":"A Rojas-Villarraga","year":"2014","unstructured":"Rojas-Villarraga, A., Torres-Gonzalez, J. V. & Ruiz-Sternberg, A. M. Safety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis. PLoS ONE 9, e104303 (2014).","journal-title":"PLoS ONE"},{"key":"503_CR191","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1756-185X.12600","volume":"20","author":"M Washio","year":"2017","unstructured":"Washio, M. et al. Risk factors for development of systemic lupus erythematosus among Japanese females: medical history and reproductive factors. Int. J. Rheum. Dis. 20, 76\u201383 (2017).","journal-title":"Int. J. Rheum. Dis."},{"key":"503_CR192","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.pcl.2018.04.001","volume":"65","author":"SE Tarvin","year":"2018","unstructured":"Tarvin, S. E. & O\u2019Neil, K. M. Systemic lupus erythematosus, Sjogren syndrome, and mixed connective tissue disease in children and adolescents. Pediatr. Clin. North. Am. 65, 711\u2013737 (2018).","journal-title":"Pediatr. Clin. North. Am."},{"key":"503_CR193","doi-asserted-by":"crossref","first-page":"J170","DOI":"10.1016\/j.jaut.2011.11.002","volume":"38","author":"A Lateef","year":"2012","unstructured":"Lateef, A. & Petri, M. Hormone replacement and contraceptive therapy in autoimmune diseases. J. Autoimmun. 38, J170\u2013J176 (2012).","journal-title":"J. Autoimmun."},{"key":"503_CR194","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","volume":"353","author":"M Petri","year":"2005","unstructured":"Petri, M. et al. Combined oral contraceptives in women with systemic lupus erythematosus. N. Engl. J. Med. 353, 2550\u20132558 (2005).","journal-title":"N. Engl. J. Med."},{"key":"503_CR195","first-page":"665","volume":"32","author":"B Mostafavi","year":"2005","unstructured":"Mostafavi, B. et al. Perinatal characteristics and risk of developing primary Sjogren\u2019s syndrome: a case-control study. J. Rheumatol. 32, 665\u2013668 (2005).","journal-title":"J. Rheumatol."},{"key":"503_CR196","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clim.2016.04.002","volume":"168","author":"VM Harris","year":"2016","unstructured":"Harris, V. M. et al. Klinefelter\u2019s syndrome (47,XXY) is in excess among men with Sjogren\u2019s syndrome. Clin. Immunol. 168, 25\u201329 (2016).","journal-title":"Clin. Immunol."},{"key":"503_CR197","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13293-017-0137-7","volume":"8","author":"JI Ramirez Sepulveda","year":"2017","unstructured":"Ramirez Sepulveda, J. I., Kvarnstrom, M., Brauner, S., Baldini, C. & Wahren-Herlenius, M. Difference in clinical presentation between women and men in incident primary Sjogren\u2019s syndrome. Biol. Sex Differ. 8, 16 (2017).","journal-title":"Biol. Sex Differ."},{"key":"503_CR198","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/03009742.2016.1158312","volume":"46","author":"C Ballester","year":"2017","unstructured":"Ballester, C. et al. Pregnancy and primary Sj\u00f6gren\u2019s syndrome: management and outcomes in a multicentre retrospective study of 54 pregnancies. Scand. J. Rheumatol. 46, 56\u201363 (2017).","journal-title":"Scand. J. Rheumatol."},{"key":"503_CR199","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7812\/TPP\/16-047","volume":"21","author":"S Gupta","year":"2017","unstructured":"Gupta, S. & Gupta, N. Sj\u00f6gren syndrome and pregnancy: a literature review. Perm. J. 21, 16\u2013047 (2017).","journal-title":"Perm. J."},{"key":"503_CR200","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/acr.24014","volume":"72","author":"SS McCoy","year":"2019","unstructured":"McCoy, S. S., Sampene, E. & Baer, A. N. Sj\u00f6gren\u2019s syndrome is associated with reduced lifetime sex hormone exposure: a case-control study. Arthritis Care Res. 72, 1315\u20131322 (2019).","journal-title":"Arthritis Care Res."},{"key":"503_CR201","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-3083.2008.02186.x","volume":"68","author":"HF d\u2019Elia","year":"2008","unstructured":"d\u2019Elia, H. F. & Carlsten, H. The impact of hormone replacement therapy on humoral and cell-mediated immune responses in vivo in post-menopausal women with rheumatoid arthritis. Scand. J. Immunol. 68, 661\u2013667 (2008).","journal-title":"Scand. J. Immunol."},{"key":"503_CR202","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/art.23325","volume":"59","author":"B Walitt","year":"2008","unstructured":"Walitt, B. et al. Effects of postmenopausal hormone therapy on rheumatoid arthritis: the Women\u2019s Health Initiative randomized controlled trials. Arthritis Rheum. 59, 302\u2013310 (2008).","journal-title":"Arthritis Rheum."},{"key":"503_CR203","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/13697130903025449","volume":"12","author":"CR Holroyd","year":"2009","unstructured":"Holroyd, C. R. & Edwards, C. J. The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus. Climacteric 12, 378\u2013386 (2009).","journal-title":"Climacteric"},{"key":"503_CR204","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3109\/03009741003742763","volume":"39","author":"E Berglin","year":"2010","unstructured":"Berglin, E., Kokkonen, H., Einarsdottir, E., Agren, A. & Rantapaa Dahlqvist, S. Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in northern Sweden: a case-control study. Scand. J. Rheumatol. 39, 454\u2013460 (2010).","journal-title":"Scand. J. Rheumatol."},{"key":"503_CR205","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1136\/ard.2009.111179","volume":"69","author":"C Salliot","year":"2010","unstructured":"Salliot, C., Bombardier, C., Saraux, A., Combe, B. & Dougados, M. Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and\/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort. Ann. Rheum. Dis. 69, 1683\u20131686 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"503_CR206","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10654-015-0004-y","volume":"30","author":"C Orellana","year":"2015","unstructured":"Orellana, C. et al. Postmenopausal hormone therapy and the risk of rheumatoid arthritis: results from the Swedish EIRA population-based case-control study. Eur. J. Epidemiol. 30, 449\u2013457 (2015).","journal-title":"Eur. J. Epidemiol."},{"key":"503_CR207","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fendo.2019.00265","volume":"10","author":"MK Desai","year":"2019","unstructured":"Desai, M. K. & Brinton, R. D. Autoimmune disease in women: endocrine transition and risk across the lifespan. Front. Endocrinol. 10, 265 (2019).","journal-title":"Front. Endocrinol."},{"key":"503_CR208","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.semarthrit.2019.09.003","volume":"50","author":"WMY Chen","year":"2020","unstructured":"Chen, W. M. Y. et al. The association between gravidity, parity and the risk of developing rheumatoid arthritis: a systematic review and meta-analysis. Semin. Arthritis Rheum. 50, 252\u2013260 (2020).","journal-title":"Semin. Arthritis Rheum."},{"key":"503_CR209","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/rheumatology\/key311","volume":"58","author":"D Alpizar-Rodriguez","year":"2019","unstructured":"Alpizar-Rodriguez, D., Forger, F., Courvoisier, D. S., Gabay, C. & Finckh, A. Role of reproductive and menopausal factors in functional and structural progression of rheumatoid arthritis: results from the SCQM cohort. Rheumatology 58, 432\u2013440 (2019).","journal-title":"Rheumatology"},{"key":"503_CR210","first-page":"15","volume":"143","author":"AT Masi","year":"1979","unstructured":"Masi, A. T. & Medsger, T. A. Jr. A new look at the epidemiology of ankylosing spondylitis and related syndromes. Clin. Orthop. Relat. Res. 143, 15\u201329 (1979).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"503_CR211","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0889-857X(21)00985-6","volume":"15","author":"M Ostensen","year":"1989","unstructured":"Ostensen, M. & Husby, G. Ankylosing spondylitis and pregnancy. Rheum. Dis. Clin. North Am. 15, 241\u2013254 (1989).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"503_CR212","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00002281-199607000-00002","volume":"8","author":"S van der Linden","year":"1996","unstructured":"van der Linden, S. & van der Heijde, D. M. Clinical and epidemiologic aspects of ankylosing spondylitis and spondyloarthropathies. Curr. Opin. Rheumatol. 8, 269\u2013274 (1996).","journal-title":"Curr. Opin. Rheumatol."},{"key":"503_CR213","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00002281-199807000-00003","volume":"10","author":"JT Gran","year":"1998","unstructured":"Gran, J. T. & Husby, G. Clinical, epidemiologic, and therapeutic aspects of ankylosing spondylitis. Curr. Opin. Rheumatol. 10, 292\u2013298 (1998).","journal-title":"Curr. Opin. Rheumatol."},{"key":"503_CR214","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/ard.2004.029538","volume":"64","author":"M Ostensen","year":"2005","unstructured":"Ostensen, M. et al. Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann. Rheum. Dis. 64, 839\u2013844 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"503_CR215","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/art.23321","volume":"59","author":"W Lee","year":"2008","unstructured":"Lee, W., Reveille, J. D. & Weisman, M. H. Women with ankylosing spondylitis: a review. Arthritis Rheum. 59, 449\u2013454 (2008).","journal-title":"Arthritis Rheum."},{"key":"503_CR216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2009.05292.x","volume":"1193","author":"J Rovensky","year":"2010","unstructured":"Rovensky, J., Imrich, R., Lazurova, I. & Payer, J. Rheumatic diseases and Klinefelter\u2019s syndrome. Ann. N. Y. Acad. Sci. 1193, 1\u20139 (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"503_CR217","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3899\/jrheum.130996","volume":"41","author":"D Mahendira","year":"2014","unstructured":"Mahendira, D. et al. Analysis of the effect of the oral contraceptive pill on clinical outcomes in women with ankylosing spondylitis. J. Rheumatol. 41, 1344\u20131348 (2014).","journal-title":"J. Rheumatol."},{"key":"503_CR218","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.autrev.2014.12.011","volume":"14","author":"M Ostensen","year":"2015","unstructured":"Ostensen, M. et al. State of the art: reproduction and pregnancy in rheumatic diseases. Autoimmun. Rev. 14, 376\u2013386 (2015).","journal-title":"Autoimmun. Rev."},{"key":"503_CR219","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","volume":"76","author":"L Andreoli","year":"2017","unstructured":"Andreoli, L. et al. EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome. Ann. Rheum. Dis. 76, 476\u2013485 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"503_CR220","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0008-8749(92)90236-I","volume":"144","author":"H Carlsten","year":"1992","unstructured":"Carlsten, H. et al. Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr\/lpr mice. Cell Immunol. 144, 190\u2013202 (1992).","journal-title":"Cell Immunol."},{"key":"503_CR221","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.imbio.2015.05.009","volume":"220","author":"AI Bernardi","year":"2015","unstructured":"Bernardi, A. I. et al. Selective estrogen receptor modulators in T cell development and T cell dependent inflammation. Immunobiology 220, 1122\u20131128 (2015).","journal-title":"Immunobiology"},{"key":"503_CR222","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/nyas.12398","volume":"1317","author":"S Capellino","year":"2014","unstructured":"Capellino, S., Straub, R. H. & Cutolo, M. Aromatase and regulation of the estrogen-to-androgen ratio in synovial tissue inflammation: common pathway in both sexes. Ann. N. Y. Acad. Sci. 1317, 24\u201331 (2014).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"503_CR223","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3899\/jrheum.080558","volume":"36","author":"B Tengstrand","year":"2009","unstructured":"Tengstrand, B., Carlstrom, K. & Hafstrom, I. Gonadal hormones in men with rheumatoid arthritis \u2014 from onset through 2 years. J. Rheumatol. 36, 887\u2013892 (2009).","journal-title":"J. Rheumatol."},{"key":"503_CR224","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.21112","volume":"52","author":"C Weidler","year":"2005","unstructured":"Weidler, C. et al. Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: a prerequisite for local androgen deficiency. Arthritis Rheum. 52, 1721\u20131729 (2005).","journal-title":"Arthritis Rheum."},{"key":"503_CR225","doi-asserted-by":"crossref","first-page":"R938","DOI":"10.1186\/ar1769","volume":"7","author":"M Schmidt","year":"2005","unstructured":"Schmidt, M., Weidler, C., Naumann, H., Sch\u00f6lmerich, J. & Straub, R. H. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes \u2014 androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5\u03b1-reduced androgens. Arthritis Res. Ther. 7, R938\u2013R948 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"503_CR226","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/art.21946","volume":"54","author":"RH Straub","year":"2006","unstructured":"Straub, R. H., H\u00e4rle, P., Sarzi-Puttini, P. & Cutolo, M. Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of antiinflammatory action. Arthritis Rheum. 54, 2039\u20132046 (2006).","journal-title":"Arthritis Rheum."},{"key":"503_CR227","first-page":"1451","volume":"34","author":"S Ernestam","year":"2007","unstructured":"Ernestam, S., Hafstrom, I., Werner, S., Carlstrom, K. & Tengstrand, B. Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function. J. Rheumatol. 34, 1451\u20131458 (2007).","journal-title":"J. Rheumatol."},{"key":"503_CR228","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3899\/jrheum.171152","volume":"45","author":"G Genest","year":"2018","unstructured":"Genest, G., Spitzer, K. A. & Laskin, C. A. Maternal and fetal outcomes in a cohort of patients exposed to tumor necrosis factor inhibitors throughout pregnancy. J. Rheumatol. 45, 1109\u20131115 (2018).","journal-title":"J. Rheumatol."},{"key":"503_CR229","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3899\/jrheum.110548","volume":"39","author":"D Jawaheer","year":"2012","unstructured":"Jawaheer, D., Olsen, J. & Hetland, M. L. Sex differences in response to anti-tumor necrosis factor therapy in early and established rheumatoid arthritis \u2014 results from the DANBIO registry. J. Rheumatol. 39, 46\u201353 (2012).","journal-title":"J. Rheumatol."},{"key":"503_CR230","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jaut.2009.02.016","volume":"32","author":"M Cutolo","year":"2009","unstructured":"Cutolo, M. et al. Sex hormones modulate the effects of leflunomide on cytokine production by cultures of differentiated monocyte\/macrophages and synovial macrophages from rheumatoid arthritis patients. J. Autoimmun. 32, 254\u2013260 (2009).","journal-title":"J. Autoimmun."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-0503-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-0503-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-0503-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T18:32:29Z","timestamp":1669055549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-0503-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,2]]},"references-count":230,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1038\/s41584-020-0503-4","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,2]]},"assertion":[{"value":"1 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}